| dc.creator | Cuchacovich T,Miguel | |
| dc.creator | Pacheco B,Patricio | |
| dc.creator | Merino B,Guillermo | |
| dc.creator | Gallardo V,Patricia | |
| dc.creator | Gatica R,Héctor | |
| dc.creator | Valenzuela H,Hernán | |
| dc.creator | Verdaguer D,Juan | |
| dc.creator | Verdaguer T,Juan | |
| dc.date | 2000-11-01 | |
| dc.date.accessioned | 2022-08-29T19:34:40Z | |
| dc.date.available | 2022-08-29T19:34:40Z | |
| dc.identifier | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/206249 | |
| dc.description | Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis. Patients and methods: Forty six patients with refractory scleritis and episcleritis were studied and treated during the period 1991 to 1998. Results: Necrotizing type was the most common and severe category in the scleritis group of patients. A decrease in vision occurred in 58.3% of patients with scleritis v/s a 23.5% of patients with epiescleritis (p<0,05). Uveitis was present in 35.4% of patients with scleritis and scleromalacia was present in 33.3% (p<0,05). A specific disease association was uncovered in 51% of scleritis and in 38% of episcleritis patients. Rheumatoid arthritis, primary systemic vasculitic disease and Sjögren syndrome with vasculitis were the most common associated systemic diseases. Three patients with scleritis had tuberculosis. Conclusions: Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information. A meticulous approach for the detection of a specific associated disease must be undertaken. Scleritis associated with vasculitis has a worse ocular prognosis than other non infectious diseases. Cyclophosphamide is the most effective inmunosuppresive treatment to control severe ocular involvement (Rev Méd Chile 2000; 128: 1205-14) | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872000001100004 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.128 n.11 2000 | |
| dc.subject | Arthritis rheumatoid | |
| dc.subject | Epiescleritis | |
| dc.subject | Scleral diseases | |
| dc.subject | Scleritis | |
| dc.subject | Sjögren syndrome | |
| dc.subject | Vasculitis | |
| dc.title | Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local | |
